KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
97 hedge funds and large institutions have $53.6M invested in Chinook Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 42 increasing their positions, 21 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
-5
Holders Change %
-4.9%
% of All Funds
2.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
42
Reduced
21
Closed
15
Calls
$66K
Puts
$3K
Net Calls
+$63K
Net Calls Change
-$208K
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$1.64M |
| 2 |
Renaissance Technologies
New York
|
+$1.01M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$466K |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$369K |
| 5 |
BlackRock
New York
|
+$339K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.67M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.13M |
| 3 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
-$673K |
| 4 |
Norges Bank
Oslo,
Norway
|
-$557K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$422K |
